Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study
暂无分享,去创建一个
M. Ciccozzi | S. Angeletti | R. Scarpa | A. Afeltra | D. Margiotta | L. Navarini | F. Caso | L. Costa | M. Tasso | D. Currado
[1] L. Puig. Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis , 2017, International journal of molecular sciences.
[2] M. Chang,et al. Underestimation of Risk of Carotid Subclinical Atherosclerosis by Cardiovascular Risk Scores in Patients with Psoriatic Arthritis , 2017, The Journal of Rheumatology.
[3] L. Eder,et al. Cardiometabolic Disorders in Psoriatic Disease , 2017, Current Rheumatology Reports.
[4] M. Martínez-Vidal,et al. Is the SCORE chart underestimating the real cardiovascular (CV) risk of patients with psoriatic arthritis? Prevalence of subclinical CV disease detected by carotid ultrasound. , 2017, Joint, bone, spine : revue du rhumatisme.
[5] M. Pletcher,et al. Cardiovascular Risk Assessment. , 2017, The Medical clinics of North America.
[6] J. Primdahl,et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update , 2016, Annals of the rheumatic diseases.
[7] D. Gladman,et al. Incidence and predictors for cardiovascular events in patients with psoriatic arthritis , 2015, Annals of the rheumatic diseases.
[8] E. Matteson,et al. Cardiovascular Risk Profile at the Onset of Psoriatic Arthritis: A Population‐Based Cohort Study , 2015, Arthritis care & research.
[9] G. Kitas,et al. Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis , 2014, Annals of the rheumatic diseases.
[10] M. R. Bongiorno,et al. Psoriasis and Cardiovascular Risk: Assessment by CUORE Project Risk Score in Italian Patients , 2013, Dermatology research and practice.
[11] D. Gladman,et al. The Framingham Risk Score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease , 2013, Annals of the rheumatic diseases.
[12] T. Therneau,et al. Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. , 2012, The American journal of cardiology.
[13] Shah Ebrahim,et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.
[14] P. Strazzullo,et al. Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study , 2012, Clinical Rheumatology.
[15] L. Punzi,et al. Atherosclerosis in psoriatic arthritis. , 2011, Autoimmunity reviews.
[16] N. Paynter,et al. C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men , 2008, Circulation.
[17] A. Sheikh,et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2 , 2008, BMJ : British Medical Journal.
[18] M. Pencina,et al. General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.
[19] N. Cook,et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. , 2007, JAMA.
[20] Dafna Gladman,et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. , 2006, Arthritis and rheumatism.
[21] D. Gladman,et al. Psoriatic Arthritis. , 2017, The New England journal of medicine.
[22] K. Yim,et al. Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms , 2016, Rheumatology International.